The National Home Infusion Association (NHIA) and more 170 physicians and physician groups, patient advocacy groups, hospitals and medical associations asked congressional leaders to quickly change provisions of the 21st Century Cures Act that they say created a reimbursement gap for Medicare Part B durable medical equipment drugs for vulnerable patients with home infusion therapy. The Cures law put in place an average sales price pay formula for Part B DME infusion drugs starting this month, but the law delayed...